51,913 Followers on Owler

Genentech

Read more
Alexander Hardy's photo - CEO of Genentech

CEO

Alexander Hardy

CEO Approval Rating

78/100

GENENTECH TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Amgen is one of Genentech's top rivals. Amgen is a Public company that was founded in 1980 in Thousand Oaks, California. Like Genentech, Amgen also works within the Biotechnology industry. Compared to Genentech, Amgen has 10,800 more employees.

Gilead is seen as one of Genentech's biggest rivals. Gilead was founded in 1987 in Foster City, California. Like Genentech, Gilead also competes in the Biotechnology sector. Gilead generates $7.3B more revenue than Genentech.

Biogen is one of Genentech's top competitors. Biogen was founded in 1978, and its headquarters is in Cambridge, Massachusetts. Like Genentech, Biogen also competes in the Biotechnology space. Biogen has 4,400 fewer employees than Genentech.

Genentech Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Jecure Therapeutics Inc.

Nov 2018

Source »
undisclosed
Jecure discovers and develops small-molecule therapeutics for the treatment of non-alcoholic steatohepatitis and liver fibrosis.
Seragon Pharmaceuticals, Inc.

Jul 2014

Source »
$725M
Seragon Pharmaceuticals is a research-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer.
Arrayit Corporation

Sep 2013

Source »
undisclosed
Arrayit develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function.

-

Biogen Idec's NIMO

Jun 2005

Source »
$408M
-

These are all the companies that Genentech has acquired. Genentech has acquired 4 companies and its latest acquisition was Jecure Therapeutics Inc. in Nov 2018. Jecure discovers and develops small-molecule therapeutics for the treatment of non-alcoholic steatohepatitis and liver fibrosis.

Genentech Funding History

Since Genentech was founded in 1976, it has participated in 2 rounds of funding. In total Genentech has raised $2.0B. Genentech's last funding round was on Jul 1999 for a total of $1.9B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jul 1999
$1.9B
-
Equity
Apr 1994
$95.4M

Since Genentech was founded in 1976, it has participated in 2 rounds of funding. In total Genentech has raised $2.0B. Genentech's last funding round was on Jul 1999 for a total of $1.9B

Genentech Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Start Codon is a business accelerator that offers funding and support programs for life science and healthcare startups.
-
Apr 22, 2019
Seed
-
Constellation is a Massachusetts-based biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer.
$95M
May 16, 2012
Corporate Round
Jul 18, 2018
Curis is a biotechnology company that focuses on the development and commercialization of therapeutics for the treatment of cancer.
$6M
Dec 21, 2011
Unattributed
Feb 23, 2015
Curis is a biotechnology company that focuses on the development and commercialization of therapeutics for the treatment of cancer.
$8M
Nov 08, 2011
Unattributed
Feb 23, 2015
23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.
-
May 21, 2007
Series A
Mar 11, 2021

These are all the companies that Genentech has invested in. Genentech has invested 8 companies and its latest investment was Start Codon in Apr 22,. Start Codon is a business accelerator that offers funding and support programs for life science and healthcare startups.

Genentech News

Genentech Press Releases

Genentech Videos

Social Media

Genentech Headquarters

1 DNA Way Mailstop 258A

South San Francisco, California94080

888-835-2555

Driving Directions »

Trending Companies

Genentech Summary

ABOUT

Overview

Genentech is a biotechnology company that discovers, develops and commercializes medicines to treat patients with life-threatening medical conditions. Genentech was founded in 1976. Genentech's headquarters is located in South San Francisco, Californi...

CEO

Genentech's CEO, Alexander Hardy, currently has an approval rating of 78%. Genentech's primary competitors are Amgen, Gilead & Biogen.

Website

gene.com

Frequently Asked Questions about Genentech

  1. When was Genentech founded?

    Genentech was founded in 1976
  2. Who is Genentech's CEO?

    Genentech's CEO is Alexander Hardy
  3. How much revenue does Genentech generate?

    Genentech generates $18.3B in revenue
  4. How much funding does Genentech have?

    Genentech has historically raised $2B in funding
  5. Where is Genentech's headquarters?

    Genentech's headquarters is in South San Francisco California, USA
  1. How many employees does Genentech have?

    Genentech has 13,500 employees
  2. What sector does Genentech operate in?

    Genentech is in Biotechnology, Pharmaceuticals
  3. Who are Genentech's competitors?

    Genentech's top competitors are Amgen, Gilead, Biogen
  4. Who has Genentech invested in?

    Genentech's has invested in companies such as Start Codon, Constellation, Curis Inc